According to Pliant Therapeutics's latest financial reports the company has C$0.58 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | C$0.65 B | 45.87% |
2022-12-31 | C$0.44 B | 75.79% |
2021-12-31 | C$0.25 B | -27.59% |
2020-12-31 | C$0.35 B | 163.03% |
2019-12-31 | C$0.13 B | 61.67% |
2018-12-31 | C$83.02 M |